133 related articles for article (PubMed ID: 22327326)
1. Possible role of matrix metalloproteinases (MMPs) in hyperostosis of intracranial meningiomas.
Pei J; Jung S; Jin SG; Moon KS; Wen M; Li SY; Jang WY; Ryu HH; Lee KH; Kim IY; Jung TY
Acta Neurochir (Wien); 2012 Apr; 154(4):611-20; discussion 620. PubMed ID: 22327326
[TBL] [Abstract][Full Text] [Related]
2. Ets-1 is up-regulated together with its target gene products matrix metalloproteinase-2 and matrix metalloproteinase-9 in atypical and anaplastic meningiomas.
Okuducu AF; Zils U; Michaelis SA; Michaelides S; von Deimling A
Histopathology; 2006 Jun; 48(7):836-45. PubMed ID: 16722933
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-2 and matrix metalloproteinase-9 expression in canine and feline meningioma.
Mandara MT; Pavone S; Mandrioli L; Bettini G; Falzone C; Baroni M
Vet Pathol; 2009 Sep; 46(5):836-45. PubMed ID: 19276056
[TBL] [Abstract][Full Text] [Related]
4. Localized cranial hyperostosis of meningiomas: a result of neoplastic enzymatic activity?
Heick A; Mosdal C; Jørgensen K; Klinken L
Acta Neurol Scand; 1993 Mar; 87(3):243-7. PubMed ID: 8475698
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases 2 and 9 in meningiomas associated with different degrees of brain invasiveness and edema.
Nordqvist AC; Smurawa H; Mathiesen T
J Neurosurg; 2001 Nov; 95(5):839-44. PubMed ID: 11702875
[TBL] [Abstract][Full Text] [Related]
6. Expression of extracellular matrix-degrading proteins in classic, atypical, and anaplastic meningiomas.
von Randow AJ; Schindler S; Tews DS
Pathol Res Pract; 2006; 202(5):365-72. PubMed ID: 16563650
[TBL] [Abstract][Full Text] [Related]
7. The role of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in microcystic meningiomas.
Paek SH; Kim DG; Park CK; Phi JH; Kim YY; Im SY; Kim JE; Park SH; Jung HW
Oncol Rep; 2006 Jul; 16(1):49-56. PubMed ID: 16786122
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinases in a series of 12 meningiomas.
Kirches E; Grunewald J; von Bossanyi P; Szibor R; Plate I; Krüger S; Warich-Kirches M; Dietzmann K
Clin Neuropathol; 2001; 20(1):26-30. PubMed ID: 11220692
[TBL] [Abstract][Full Text] [Related]
9. Management of bone-invasive, hyperostotic sphenoid wing meningiomas.
Bikmaz K; Mrak R; Al-Mefty O
J Neurosurg; 2007 Nov; 107(5):905-12. PubMed ID: 17977259
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of avian erythroblastosis virus E26 oncogene homolog 1 in World Health Organization grade 1 meningiomas is associated with an elevated risk of recurrence and is correlated with the expression of its target genes matrix metalloproteinase-2 and MMP-9.
Okuducu AF; Zils U; Michaelis SA; Mawrin C; von Deimling A
Cancer; 2006 Sep; 107(6):1365-72. PubMed ID: 16894529
[TBL] [Abstract][Full Text] [Related]
11. Expression of MMP-2 and MMP-9 in benign canine rostrotentorial meningiomas is not correlated to the extent of peritumoral edema.
Beltran E; Matiasek K; De Risio L; de Stefani A; Feliu-Pascual AL; Matiasek LA
Vet Pathol; 2013 Nov; 50(6):1091-8. PubMed ID: 23528939
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological characteristics, hormone receptor status and matrix metallo-proteinase-9 (MMP-9) immunohistochemical expression in spinal meningiomas.
Barresi V; Alafaci C; Caffo M; Barresi G; Tuccari G
Pathol Res Pract; 2012 Jun; 208(6):350-5. PubMed ID: 22494536
[TBL] [Abstract][Full Text] [Related]
13. A giant hyperostosing meningioma in a child.
Cataltepe O; Ekin Ozcan O; Sagmanli S; Onol B
Neurochirurgia (Stuttg); 1992 Sep; 35(5):171-5. PubMed ID: 1436369
[TBL] [Abstract][Full Text] [Related]
14. Expression of MMP-2 and -9 in short-term cultures of meningioma: influence of histological subtype.
Rooprai HK; van Meter TE; Robinson SD; King A; Rucklidge GJ; Pilkington GJ
Int J Mol Med; 2003 Dec; 12(6):977-81. PubMed ID: 14612977
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid stimulates meningioma cell adhesion to the extracellular matrix and inhibits invasion.
Pereda MP; Hopfner U; Pagotto U; Renner U; Uhl E; Arzt E; Missale C; Stalla GK
Br J Cancer; 1999 Oct; 81(3):381-6. PubMed ID: 10507760
[TBL] [Abstract][Full Text] [Related]
17. Increased immunoreactivity of membrane type-1 matrix metalloproteinase (MT1-MMP) and β-catenin in high-risk basal cell carcinoma.
Oh ST; Kim HS; Yoo NJ; Lee WS; Cho BK; Reichrath J
Br J Dermatol; 2011 Dec; 165(6):1197-204. PubMed ID: 21729023
[TBL] [Abstract][Full Text] [Related]
18. Does bony hyperostosis in intracranial meningioma signify tumor invasion? A radio-pathologic study.
Goyal N; Kakkar A; Sarkar C; Agrawal D
Neurol India; 2012; 60(1):50-4. PubMed ID: 22406780
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of extracellular matrix-related genes in rare variants of meningioma.
Kwon MJ; Sung CO; Kang SY; Do IG; Suh YL
Hum Pathol; 2013 Feb; 44(2):260-8. PubMed ID: 22995327
[TBL] [Abstract][Full Text] [Related]
20. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
